|
|
Home | Submit Press Release | Advertise | Submit Website
(CityRegions.Com, September 18, 2018 ) Biosimulation market is projected to reach USD 2.88 Billion by 2022 from USD 1.38 Billion in 2017, at a CAGR of 15.9%. Factors like increase in R&D investments in pharmaceutical & biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery & development costs.
Download the Brochure of Biosimulation Market report with 149 market data Tables with 57 Figures across 318 Pages and in-depth TOC at http://www.reportsnreports.com/contacts/requestsample.aspx?name=199952 .
Biosimulation market report will help stakeholders to understand competitive landscape better & gain insights to position their businesses & help companies make suitable go-to-market strategies. Report also helps stakeholders understand pulse of market & provide them with information regarding key market drivers & opportunities.
Biosimulation Market by Software
• Molecular Modeling and Simulation Software
• PBPK Modeling and Simulation Software
• PK/PD Modeling and Simulation Software
• Trial Design Software
• Toxicity Prediction Software
Biosimulation Market By End User
• Pharmaceutical and Biotechnology Companies
• Research Institutes
• Contract Research Organizations
• Regulatory Authorities
Click Now for More Discount on Biosimulation Market Report with Top Trends, Forecast, Analysis and Overview at http://www.reportsnreports.com/contacts/discount.aspx?name=199952 .
North America is expected to account for the largest share of the market followed by Europe. However, Europe is expected to register the highest CAGR during the forecast period. The growing focus on research-related funding activities by governments is expected to assist in the development of drug discovery and development process, thus driving the demand for biosimulation in European region.
Target Audience for Biosimulation Market Report:
• Biosimulation product manufacturers, vendors, and distributors
• Market research and consulting companies
• Regulatory authorities
• Associations related to pharmaceutical and biotechnology research
• Biotechnology and pharmaceutical companies
• Academic and government research institutes
• Contract research organizations (CROs)
More information on “Biosimulation Market by Product (Software, Molecular Simulation, In House, Contract Services), Application (Clinical Trials, PKPD, ADME), Delivery (Subscription, Ownership), End User (Biotech, Pharma Companies, CROs, Regulatory) - Global Forecast to 2022” research report can be requested at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=199952 .
Top players in biosimulation market operating are Certara (US), Simulation Plus (US), Dassault Systèmes (France), Schrödinger (US), ACD/Labs (Canada), Chemical Computing Group (Canada), Physiomics (UK), Evidera (US), In silico biosciences (US), INOSIM Software (Germany), Insilico Biotechnology (Germany), LeadInvent Technologies (India), Rosa (US), Nuventra Pharma (US), and Genedata (Switzerland).
Premium Insights
1 Biosimulation Market Overview
2 Biosimulation Software Market, By Type
3 Geographic Analysis: Biosimulation Market in Europe, By End User and Country
4 Biosimulation Drug Developement Market, By Type
ReportsnReports
Mr. Hrishikesh
+ 18883915441
sales@reportsandreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
